Senior insider sale
See Remarks at CANDEL THERAPEUTICS, INC. — senior position signals high conviction
$152.2K
14K shares
What this filing means
TYAGARAJAN SESHU plans to sell 14K shares of CANDEL THERAPEUTICS, INC. valued at approximately $152.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001950047-26-008263
Officer· See Remarks
Since Apr 2022
14K
Shares to sell
$152.2K
Approx. market value
7K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/7/2025
7KTotal acquired7K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/7/2025 | Restricted Stock Units N/A | 7K | — |
| Total | 7K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7K
Market value
$70.2K
6/29/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7K
Market value
$82.0K
8/17/2026
Total
Units
14K
Value
$152.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/29/2026 | 7K | $70.2K | — | Completed |
| Planned — Approximate Date | ||||
8/17/2026 | 7K | $82.0K | NASDAQ | Planned |
| Total | 14K | $152.2K | ||